Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tinzaparin sodium 4,500units/0.45ml inj pre-filled syringes
0208010W0AAAMAM
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 2,245 |
|
Tinzaparin sodium 14,000units/0.7ml inj pre-filled syringes
0208010W0AAAIAI
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 2,103 |
|
Tinzaparin sodium 12,000units/0.6ml inj pre-filled syringes
0208010W0AAASAS
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 1,904 |
|
Tinzaparin sodium 10,000units/0.5ml inj pre-filled syringes
0208010W0AAAKAK
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 1,776 |
|
Tinzaparin sodium 16,000units/0.8ml inj pre-filled syringes
0208010W0AAARAR
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 1,291 |
|
Tinzaparin sodium 18,000units/0.9ml inj pre-filled syringes
0208010W0AAAJAJ
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 1,180 |
|
Tinzaparin sodium 8,000units/0.4ml inj pre-filled syringes
0208010W0AAATAT
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 877 |
|
Tinzaparin sodium 3,500units/0.35ml inj pre-filled syringes
0208010W0AAALAL
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 797 |
|
Tinzaparin sodium 2,500units/0.25ml inj pre-filled syringes
0208010W0AAAQAQ
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 146 |
|
Tinzaparin sodium 20,000units/2ml inj vials
0208010W0AAANAN
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 97 |
|
Tinzaparin sodium 40,000units/2ml inj vials
0208010W0AAAFAF
|
Tinzaparin sodium | Tinzaparin sodium | Cardiovascular System | 26 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.